Telomir Pharmaceuticals secures $3M in straight equity sale

9 hours ago 1

Telomir Pharmaceuticals (NASDAQ:TELO) said on Wednesday that it has secured $3M in equity financing, through a direct investment by The Bayshore Trust, the company's largest shareholder.
The transaction involved the purchase of 1M restricted shares of the company's common stock

Recommended For You